These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 38497113)
1. Kynurenine 3-monooxygenase limits de novo NAD Zhai Y; Chavez JA; D'Aquino KE; Meng R; Nawrocki AR; Pocai A; Wang L; Ma LJ Am J Physiol Cell Physiol; 2024 May; 326(5):C1423-C1436. PubMed ID: 38497113 [TBL] [Abstract][Full Text] [Related]
2. Kynurenine 3-monooxygenase is a critical regulator of renal ischemia-reperfusion injury. Zheng X; Zhang A; Binnie M; McGuire K; Webster SP; Hughes J; Howie SEM; Mole DJ Exp Mol Med; 2019 Feb; 51(2):1-14. PubMed ID: 30760699 [TBL] [Abstract][Full Text] [Related]
3. Kynurenine 3-Monooxygenase Activity in Human Primary Neurons and Effect on Cellular Bioenergetics Identifies New Neurotoxic Mechanisms. Castellano-Gonzalez G; Jacobs KR; Don E; Cole NJ; Adams S; Lim CK; Lovejoy DB; Guillemin GJ Neurotox Res; 2019 Apr; 35(3):530-541. PubMed ID: 30666558 [TBL] [Abstract][Full Text] [Related]
4. Targeted deletion of kynurenine 3-monooxygenase in mice: a new tool for studying kynurenine pathway metabolism in periphery and brain. Giorgini F; Huang SY; Sathyasaikumar KV; Notarangelo FM; Thomas MA; Tararina M; Wu HQ; Schwarcz R; Muchowski PJ J Biol Chem; 2013 Dec; 288(51):36554-66. PubMed ID: 24189070 [TBL] [Abstract][Full Text] [Related]
5. A Minimal Kynurenine Pathway Was Preserved for Rhodoquinone but Not for Comas-Ghierra R; Alshaheeb A; McReynolds MR; Shepherd JN; Salinas G Antioxid Redox Signal; 2024 May; 40(13-15):737-750. PubMed ID: 37639366 [No Abstract] [Full Text] [Related]
6. Hepatic steatosis induced in C57BL/6 mice by a non-ß oxidizable fatty acid analogue is associated with reduced plasma kynurenine metabolites and a modified hepatic NAD Berge RK; Cacabelos D; Señarís R; Nordrehaug JE; Nygård O; Skorve J; Bjørndal B Lipids Health Dis; 2020 May; 19(1):94. PubMed ID: 32410680 [TBL] [Abstract][Full Text] [Related]
7. Unraveling the nexus of NAD+ metabolism and diabetic kidney disease: insights from murine models and human data. Yang S; Gong W; Wang Y; Hao C; Guan Y Front Endocrinol (Lausanne); 2024; 15():1384953. PubMed ID: 38836233 [TBL] [Abstract][Full Text] [Related]
8. Differential role of nicotinamide adenine dinucleotide deficiency in acute and chronic kidney disease. Faivre A; Katsyuba E; Verissimo T; Lindenmeyer M; Rajaram RD; Naesens M; Heckenmeyer C; Mottis A; Feraille E; Cippà P; Cohen C; Longchamp A; Allagnat F; Rutkowski JM; Legouis D; Auwerx J; de Seigneux S Nephrol Dial Transplant; 2021 Jan; 36(1):60-68. PubMed ID: 33099633 [TBL] [Abstract][Full Text] [Related]
9. Kynurenine 3-monooxygenase is implicated in antidepressants-responsive depressive-like behaviors and monoaminergic dysfunctions. Tashiro T; Murakami Y; Mouri A; Imamura Y; Nabeshima T; Yamamoto Y; Saito K Behav Brain Res; 2017 Jan; 317():279-285. PubMed ID: 27693848 [TBL] [Abstract][Full Text] [Related]
11. The metabolites of Wang Y; Guan Y; Xie Q; Gong W; Li J; Chen T; Xu Y; Xu N; Chen S; Chen M; Wang Z; Hao CM Clin Kidney J; 2023 Apr; 16(4):711-721. PubMed ID: 37007695 [TBL] [Abstract][Full Text] [Related]
12. Cell stress response impairs de novo NAD+ biosynthesis in the kidney. Bignon Y; Rinaldi A; Nadour Z; Poindessous V; Nemazanyy I; Lenoir O; Fohlen B; Weill-Raynal P; Hertig A; Karras A; Galichon P; Naesens M; Anglicheau D; Cippà PE; Pallet N JCI Insight; 2022 Jan; 7(1):. PubMed ID: 34793337 [TBL] [Abstract][Full Text] [Related]
13. Protective Role of Kynurenine 3-Monooxygenase in Allograft Rejection and Tubular Injury in Kidney Transplantation. Lassiter R; Merchen TD; Fang X; Wang Y Front Immunol; 2021; 12():671025. PubMed ID: 34305900 [TBL] [Abstract][Full Text] [Related]
14. Quinolinate as a Marker for Kynurenine Metabolite Formation and the Unresolved Question of NAD Moffett JR; Arun P; Puthillathu N; Vengilote R; Ives JA; Badawy AA; Namboodiri AM Front Immunol; 2020; 11():31. PubMed ID: 32153556 [TBL] [Abstract][Full Text] [Related]
15. Alterations in Kynurenine and NAD Wnorowski A; Wnorowska S; Kurzepa J; Parada-Turska J Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948292 [TBL] [Abstract][Full Text] [Related]
17. Genetic variants of the kynurenine-3-monooxygenase and postpartum depressive symptoms after cesarean section in Chinese women. Wang SY; Duan KM; Tan XF; Yin JY; Mao XY; Zheng W; Wang CY; Yang M; Peng C; Zhou HH; Liu ZQ J Affect Disord; 2017 Jun; 215():94-101. PubMed ID: 28319697 [TBL] [Abstract][Full Text] [Related]
18. Insulin resistance and dysregulation of tryptophan-kynurenine and kynurenine-nicotinamide adenine dinucleotide metabolic pathways. Oxenkrug G Mol Neurobiol; 2013 Oct; 48(2):294-301. PubMed ID: 23813101 [TBL] [Abstract][Full Text] [Related]
19. A novel causative role of imbalanced kynurenine pathway in ulcerative colitis: Upregulation of KMO and KYNU promotes intestinal inflammation. Shi Y; Luo S; Zhai J; Chen Y Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166929. PubMed ID: 37918679 [TBL] [Abstract][Full Text] [Related]
20. Activation of NAD(P)H oxidase by tryptophan-derived 3-hydroxykynurenine accelerates endothelial apoptosis and dysfunction in vivo. Wang Q; Zhang M; Ding Y; Wang Q; Zhang W; Song P; Zou MH Circ Res; 2014 Jan; 114(3):480-92. PubMed ID: 24281189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]